Louis Gendron, PhD - Publications

Affiliations: 
2006- Pharmacology-Physiology Université de Sherbrooke, Sherbrooke, Québec, Canada 
Area:
Pain, opioids

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Lecomte CG, Mari S, Audet J, Merlet AN, Harnie J, Beaulieu C, Abdallah K, Gendron L, Rybak IA, Prilutsky BI, Frigon A. Modulation of the gait pattern during split-belt locomotion after lateral spinal cord hemisection in adult cats. Journal of Neurophysiology. 128: 1593-1616. PMID 36382895 DOI: 10.1152/jn.00230.2022  0.587
2022 Quirion B, Beaulieu C, Côté L, Parent JL, Gendron L. Distribution of delta and mu opioid receptor mRNA in rodent dorsal root ganglia neurons. The European Journal of Neuroscience. PMID 35674691 DOI: 10.1111/ejn.15733  0.337
2022 Degrandmaison J, Rochon-Haché S, Parent JL, Gendron L. Knock-In Mouse Models to Investigate the Functions of Opioid Receptors . Frontiers in Cellular Neuroscience. 16: 807549. PMID 35173584 DOI: 10.3389/fncel.2022.807549  0.421
2021 Degrandmaison J, Grisé O, Parent JL, Gendron L. Differential barcoding of opioid receptors trafficking. Journal of Neuroscience Research. PMID 34559903 DOI: 10.1002/jnr.24949  0.501
2020 Gonzalez S, Dumitrascuta M, Eiselt E, Louis S, Kunze L, Blasiol A, Vivancos M, Previti S, Dewolf E, Martin C, Tourwè D, Cavelier F, Gendron L, Sarret P, Spetea M, et al. Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies. Journal of Medicinal Chemistry. PMID 32902268 DOI: 10.1021/Acs.Jmedchem.0C01376  0.694
2020 Degrandmaison J, Abdallah K, Blais V, Génier S, Lalumière MP, Bergeron F, Cahill CM, Boulter J, Lavoie CL, Parent JL, Gendron L. In vivo mapping of a GPCR interactome using knockin mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 32457152 DOI: 10.1073/Pnas.1917906117  0.704
2020 Quirion B, Bergeron F, Blais V, Gendron L. The Delta-Opioid Receptor; a Target for the Treatment of Pain. Frontiers in Molecular Neuroscience. 13: 52. PMID 32431594 DOI: 10.3389/Fnmol.2020.00052  0.499
2020 Eiselt E, Otis V, Belleville K, Yang G, Larocque A, Regina A, Demeule M, Sarret P, Gendron L. Use of a non-invasive brain penetrating peptide-drug conjugate strategy to improve the delivery of opioid pain relief medications to the brain. The Journal of Pharmacology and Experimental Therapeutics. PMID 32327529 DOI: 10.1124/Jpet.119.263566  0.641
2020 Berthiaume S, Abdallah K, Blais V, Gendron L. Alleviating pain with delta opioid receptor agonists: evidence from experimental models. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 32189076 DOI: 10.1007/S00702-020-02172-4  0.756
2019 Claff T, Yu J, Blais V, Patel N, Martin C, Wu L, Han GW, Holleran BJ, Van der Poorten O, White KL, Hanson MA, Sarret P, Gendron L, Cherezov V, Katritch V, et al. Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists. Science Advances. 5: eaax9115. PMID 31807708 DOI: 10.1126/Sciadv.Aax9115  0.713
2019 Eiselt E, Gonzalez S, Martin C, Chartier M, Betti C, Longpré JM, Cavelier F, Tourwè D, Gendron L, Ballet S, Sarret P. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia. Acs Chemical Neuroscience. PMID 31589400 DOI: 10.1021/Acschemneuro.9B00390  0.669
2019 Gharagozloo M, Mahmoud S, Simard C, Yamamoto K, Bobbala D, Ilangumaran S, Smith MD, Lamontagne A, Jarjoura S, Denault JB, Blais V, Gendron L, Vilariño-Güell C, Sadovnick AD, Ting JP, et al. NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity. Plos Biology. 17: e3000451. PMID 31525189 DOI: 10.1371/Journal.Pbio.3000451  0.302
2019 Gendron L, Nagi K, Zeghal M, Giguère PM, Pineyro G. Molecular aspects of delta opioid receptors. Vitamins and Hormones. 111: 49-90. PMID 31421707 DOI: 10.1016/Bs.Vh.2019.06.001  0.5
2019 Eiselt E, Côté J, Longpré JM, Blais V, Sarret P, Gendron L. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio. European Journal of Pharmacology. PMID 30707956 DOI: 10.1016/J.Ejphar.2019.01.048  0.705
2019 Jean-Louis B, Blais VD, Holleran BJ, Bergeron A, Pineyro G, Guérin B, Gendron L, Dory YL. N-guanidyl and C-tetrazole Leu-Enkephalin Derivatives: Efficient Mu and Delta Opioid Receptor Agonists with Improved Pharmacological Properties. Acs Chemical Neuroscience. PMID 30614675 DOI: 10.1021/Acschemneuro.8B00550  0.474
2018 Willemse T, Eiselt E, Hollanders K, Schepens W, van Vlijmen HWT, Chung NN, Blais V, Holleran B, Longpré JM, Schiller PW, Maes BUW, Sarret P, Gendron L, Ballet S. Corrigendum to "Chemical space screening around Phe in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings" [Bioorg. Med. Chem. Lett. 28(13) (2018) 2320-2323]. Bioorganic & Medicinal Chemistry Letters. PMID 30195888 DOI: 10.1016/J.Bmcl.2018.08.023  0.594
2018 Willemse T, Eiselt E, Hollanders K, Schepens W, van Vlijmen HWT, Chung NN, Blais V, Holleran B, Longpré JM, Schiller PW, Maes BUW, Sarret P, Gendron L, Ballet S. Chemical space screening around Phe in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings. Bioorganic & Medicinal Chemistry Letters. PMID 29853330 DOI: 10.1016/J.Bmcl.2018.05.015  0.674
2018 Abdallah K, Nadeau F, Bergeron F, Blouin S, Blais V, Bradbury KM, Lavoie CL, Parent JL, Gendron L. Adeno-associated virus 2/9 delivery of Cre recombinase in mouse primary afferents. Scientific Reports. 8: 7321. PMID 29743652 DOI: 10.1038/S41598-018-25626-Y  0.635
2018 Henry MS, Bisht K, Vernoux N, Gendron L, Torres-Berrio A, Drolet G, Tremblay MÈ. Delta Opioid Receptor Signaling Promotes Resilience to Stress Under the Repeated Social Defeat Paradigm in Mice. Frontiers in Molecular Neuroscience. 11: 100. PMID 29681795 DOI: 10.3389/Fnmol.2018.00100  0.352
2018 Bella Ndong D, Blais V, Holleran BJ, Proteau-Gagné A, Cantin-Savoie I, Robert W, Nadon J, Beauchemin S, Leduc R, Piñeyro G, Guérin B, Gendron L, Dory YL. Exploration of the fifth position of leu-enkephalin and its role in binding and activating delta (DOP) and mu (MOP) opioid receptors Peptide Science. 111: e24070. DOI: 10.1002/Pep2.24070  0.517
2017 Charfi I, Abdallah K, Gendron L, Pineyro G. Delta opioid receptors recycle to the membrane after sorting to the degradation path. Cellular and Molecular Life Sciences : Cmls. PMID 29288293 DOI: 10.1007/S00018-017-2732-5  0.717
2017 Van der Poorten O, Van Den Hauwe R, Eiselt E, Betti C, Guillemyn K, Chung NN, Hallé F, Bihel F, Schiller PW, Tourwé D, Sarret P, Gendron L, Ballet S. χ-Space Screening of Dermorphin-Based Tetrapeptides through Use of Constrained Arylazepinone and Quinolinone Scaffolds. Acs Medicinal Chemistry Letters. 8: 1177-1182. PMID 29152051 DOI: 10.1021/Acsmedchemlett.7B00347  0.659
2017 Henry MS, Gendron L, Tremblay ME, Drolet G. Enkephalins: Endogenous Analgesics with an Emerging Role in Stress Resilience. Neural Plasticity. 2017: 1546125. PMID 28781901 DOI: 10.1155/2017/1546125  0.405
2017 Abdallah K, Gendron L. The Delta Opioid Receptor in Pain Control. Handbook of Experimental Pharmacology. PMID 28510066 DOI: 10.1007/164_2017_32  0.712
2017 Pirisedigh A, Blais V, Ait-Mohand S, Abdallah K, Holleran BJ, Leduc R, Dory YL, Gendron L, Guérin B. Synthesis and Evaluation of a (64)Cu-Conjugate, a Selective δ-Opioid Receptor Positron Emission Tomography Imaging Agent. Organic Letters. PMID 28368122 DOI: 10.1021/Acs.Orglett.7B00575  0.665
2016 St-Louis É, Degrandmaison J, Grastilleur S, Génier S, Blais V, Lavoie C, Parent JL, Gendron L. Involvement of the coatomer protein complex I in the intracellular traffic of the delta opioid receptor. Molecular and Cellular Neurosciences. PMID 28041939 DOI: 10.1016/J.Mcn.2016.12.005  0.399
2016 Nadon JF, Rochon K, Grastilleur S, Langlois G, Dao TT, Blais V, Guérin B, Gendron L, Dory YL. Synthesis of Gly-Ψ[(Z)CF=CH]-Phe, a fluoroalkene dipeptide isostere and its incorporation into a Leu-enkephalin peptidomimetic. Acs Chemical Neuroscience. PMID 27762555 DOI: 10.1021/Acschemneuro.6B00163  0.337
2016 Gendron L, Cahill CM, von Zastrow M, Schiller PW, Pineyro G. Molecular Pharmacology of δ-Opioid Receptors. Pharmacological Reviews. 68: 631-700. PMID 27343248 DOI: 10.1124/Pr.114.008979  0.559
2016 Maltais J, Simard E, Froehlich U, Denault J, Gendron L, Grandbois M. iRAGE AS A NOVEL CARBOXYMETHYLATED PEPTIDE THAT PREVENTS AGE-INDUCED APOPTOSIS AND ENDOPLASMIC RETICULUM STRESS IN VASCULAR SMOOTH MUSCLE CELLS Journal of the International Society of Antioxidants in Nutrition & Health. 3. DOI: 10.18143/Jisanh_V3I2_1010  0.32
2015 Maltais JS, Simard E, Froehlich U, Denault JB, Gendron L, Grandbois M. iRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth muscle cells. Pharmacological Research. PMID 26707030 DOI: 10.1016/J.Phrs.2015.12.015  0.318
2015 Beaudry H, Gendron L, Morón JA. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain. The European Journal of Neuroscience. 41: 901--7. PMID 25639561 DOI: 10.1111/Ejn.12829  0.805
2015 Beaudry H, Mercier-Blais AA, Delaygue C, Lavoie C, Parent JL, Neugebauer W, Gendron L. Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5. British Journal of Pharmacology. 172: 2573-87. PMID 25598508 DOI: 10.1111/bph.13088  0.789
2015 Gendron L, Mittal N, Beaudry H, Walwyn W. Recent advances on the δ opioid receptor: from trafficking to function. British Journal of Pharmacology. 172: 403-19. PMID 24665909 DOI: 10.1111/Bph.12706  0.778
2014 Thomas JB, Giddings AM, Wiethe RW, Olepu S, Warner KR, Sarret P, Gendron L, Longpre JM, Zhang Y, Runyon SP, Gilmour BP. Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2. Journal of Medicinal Chemistry. 57: 7472-7. PMID 25157640 DOI: 10.1021/Jm500857R  0.616
2014 Bourassa P, Tudashki HB, Pineyro G, Grandbois M, Gendron L. Label-free monitoring of μ-opioid receptor-mediated signaling. Molecular Pharmacology. 86: 138-49. PMID 24874699 DOI: 10.1124/Mol.114.093450  0.477
2014 Thomas JB, Giddings AM, Wiethe RW, Olepu S, Warner KR, Sarret P, Gendron L, Longpre JM, Zhang Y, Runyon SP, Gilmour BP. Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound. Journal of Medicinal Chemistry. 57: 5318-32. PMID 24856674 DOI: 10.1021/Jm5003843  0.6
2014 Desroches J, Bouchard JF, Gendron L, Beaulieu P. Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia. Neuroscience. 261: 23-42. PMID 24365460 DOI: 10.1016/J.Neuroscience.2013.12.030  0.535
2013 Proteau-Gagné A, Rochon K, Roy M, Albert PJ, Guérin B, Gendron L, Dory YL. Systematic replacement of amides by 1,4-disubstituted[1,2,3]triazoles in Leu-enkephalin and the impact on the delta opioid receptor activity. Bioorganic & Medicinal Chemistry Letters. 23: 5267-9. PMID 23988352 DOI: 10.1016/J.Bmcl.2013.08.020  0.376
2013 Normandin A, Luccarini P, Molat JL, Gendron L, Dallel R. Spinal μ and δ opioids inhibit both thermal and mechanical pain in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11703-14. PMID 23843537 DOI: 10.1523/Jneurosci.1631-13.2013  0.464
2013 Rochon K, Proteau-Gagné A, Bourassa P, Nadon JF, Côté J, Bournival V, Gobeil F, Guérin B, Dory YL, Gendron L. Preparation and evaluation at the delta opioid receptor of a series of linear leu-enkephalin analogues obtained by systematic replacement of the amides. Acs Chemical Neuroscience. 4: 1204-16. PMID 23650868 DOI: 10.1021/Cn4000583  0.372
2013 Cabañero D, Baker A, Zhou S, Hargett GL, Irie T, Xia Y, Beaudry H, Gendron L, Melyan Z, Carlton SM, Morón JA. Pain after discontinuation of morphine treatment is associated with synaptic increase of GluA4-containing AMPAR in the dorsal horn of the spinal cord. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1472-84. PMID 23403695 DOI: 10.1038/Npp.2013.46  0.781
2012 Parent AJ, Beaudet N, Beaudry H, Bergeron J, Bérubé P, Drolet G, Sarret P, Gendron L. Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behavioural Brain Research. 229: 160-7. PMID 22245257 DOI: 10.1016/J.Bbr.2012.01.001  0.764
2011 Beaudry H, Dubois D, Gendron L. Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 13068-77. PMID 21917790 DOI: 10.1523/Jneurosci.1817-11.2011  0.809
2011 Otis V, Sarret P, Gendron L. Spinal activation of delta opioid receptors alleviates cancer-related bone pain. Neuroscience. 183: 221-9. PMID 21458544 DOI: 10.1016/J.Neuroscience.2011.03.052  0.678
2011 Bournival V, Desjardins R, Campbell S, Roberge C, Doueik A, Gendron L, Payet MD, Gallo-Payet N, Day R, Praud JP. Presence of task-1 channel in the laryngeal mucosa in the newborn lamb. Experimental Lung Research. 37: 205-11. PMID 21309733 DOI: 10.3109/01902148.2010.536610  0.525
2011 Desroches J, Bouchard J, Gendron L, Beaulieu P. Involvement of the cannabinoid system in the antinociception induced by opioids Pharmacological Reports. 63: 220. DOI: 10.1016/S1734-1140(11)70436-4  0.493
2010 Proteau-Gagné A, Bournival V, Rochon K, Dory YL, Gendron L. Exploring the Backbone of Enkephalins To Adjust Their Pharmacological Profile for the δ-Opioid Receptor. Acs Chemical Neuroscience. 1: 757-69. PMID 22778812 DOI: 10.1021/Cn1000759  0.403
2010 Doré-Savard L, Otis V, Belleville K, Lemire M, Archambault M, Tremblay L, Beaudoin JF, Beaudet N, Lecomte R, Lepage M, Gendron L, Sarret P. Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain. Plos One. 5: e13774. PMID 21048940 DOI: 10.1371/Journal.Pone.0013774  0.587
2010 Dubois D, Gendron L. Delta opioid receptor-mediated analgesia is not altered in preprotachykinin A knockout mice. The European Journal of Neuroscience. 32: 1921-9. PMID 21044181 DOI: 10.1111/J.1460-9568.2010.07466.X  0.446
2010 Roussy G, Beaudry H, Lafrance M, Belleville K, Beaudet N, Wada K, Gendron L, Sarret P. Altered morphine-induced analgesia in neurotensin type 1 receptor null mice. Neuroscience. 170: 1286-94. PMID 20727387 DOI: 10.1016/J.Neuroscience.2010.08.016  0.826
2009 Beaudry H, Proteau-Gagné A, Li S, Dory Y, Chavkin C, Gendron L. Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents. Neuroscience. 161: 381-91. PMID 19328839 DOI: 10.1016/J.Neuroscience.2009.03.053  0.803
2007 Gendron L, Pintar JE, Chavkin C. Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia. Neuroscience. 150: 807-17. PMID 17997230 DOI: 10.1016/J.Neuroscience.2007.09.060  0.721
2007 Xu M, Bruchas MR, Ippolito DL, Gendron L, Chavkin C. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 2570-81. PMID 17344394 DOI: 10.1523/Jneurosci.3728-06.2007  0.786
2007 Sharif N, Gendron L, Wowchuk J, Sarret P, Mazella J, Beaudet A, Stroh T. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2. Endocrinology. 148: 2095-105. PMID 17272399 DOI: 10.1210/En.2006-1266  0.647
2007 Gendron L, Esdaile MJ, Mennicken F, Pan H, O'Donnell D, Vincent JP, Devi LA, Cahill CM, Stroh T, Beaudet A. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin. Neuroscience. 144: 263-74. PMID 17055663 DOI: 10.1016/J.Neuroscience.2006.08.077  0.634
2006 Beaudry H, Gendron L, Guimond MO, Payet MD, Gallo-Payet N. Involvement of protein kinase C alpha (PKC alpha) in the early action of angiotensin II type 2 (AT2) effects on neurite outgrowth in NG108-15 cells: AT2-receptor inhibits PKC alpha and p21ras activity. Endocrinology. 147: 4263-72. PMID 16740968 DOI: 10.1210/En.2006-0411  0.719
2006 Perron A, Sharif N, Gendron L, Lavallée M, Stroh T, Mazella J, Beaudet A. Sustained neurotensin exposure promotes cell surface recruitment of NTS2 receptors. Biochemical and Biophysical Research Communications. 343: 799-808. PMID 16564027 DOI: 10.1016/J.Bbrc.2006.03.047  0.595
2006 Gendron L, Lucido AL, Mennicken F, O'Donnell D, Vincent JP, Stroh T, Beaudet A. Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 953-62. PMID 16421315 DOI: 10.1523/Jneurosci.3598-05.2006  0.832
2005 Lucido AL, Morinville A, Gendron L, Stroh T, Beaudet A. Prolonged morphine treatment selectively increases membrane recruitment of delta-opioid receptors in mouse basal ganglia. Journal of Molecular Neuroscience : Mn. 25: 207-14. PMID 15800374 DOI: 10.1385/Jmn:25:3:207  0.814
2005 Perron A, Sarret P, Gendron L, Stroh T, Beaudet A. Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system. The Journal of Biological Chemistry. 280: 10219-27. PMID 15637074 DOI: 10.1074/Jbc.M410557200  0.709
2004 Gendron L, Perron A, Payet MD, Gallo-Payet N, Sarret P, Beaudet A. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2. Molecular Pharmacology. 66: 1421-30. PMID 15361549 DOI: 10.1124/Mol.104.002303  0.723
2004 Gallo-Payet N, Gendron L, Chamoux E, Payet MD. AT2 Receptor of Angiotensin II and Cellular Differentiation Handbook of Experimental Pharmacology. 163: 399-422. DOI: 10.1007/978-3-642-18495-6_18  0.441
2003 Gendron L, Payet MD, Gallo-Payet N. The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms. Journal of Molecular Endocrinology. 31: 359-72. PMID 14664700 DOI: 10.1677/Jme.0.0310359  0.429
2003 Gendron L, Oligny JF, Payet MD, Gallo-Payet N. Cyclic AMP-independent involvement of Rap1/B-Raf in the angiotensin II AT2 receptor signaling pathway in NG108-15 cells. The Journal of Biological Chemistry. 278: 3606-14. PMID 12464615 DOI: 10.1074/Jbc.M202446200  0.388
2002 Sarret P, Gendron L, Kilian P, Nguyen HM, Gallo-Payet N, Payet MD, Beaudet A. Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells. The Journal of Biological Chemistry. 277: 36233-43. PMID 12084713 DOI: 10.1074/Jbc.M202586200  0.713
2002 Gendron L, Côté F, Payet MD, Gallo-Payet N. Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells. Neuroendocrinology. 75: 70-81. PMID 11810036 DOI: 10.1159/000048222  0.346
1999 Gendron L, Laflamme L, Rivard N, Asselin C, Payet MD, Gallo-Payet N. Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells. Molecular Endocrinology (Baltimore, Md.). 13: 1615-26. PMID 10478850 DOI: 10.1210/Mend.13.9.0344  0.385
1998 Gendron L, Laflamme L, Asselin C, Payet MD, Gallo-Payet N. A role for p21ras in the angiotensin II AT2 receptor transduction pathway. Endocrine Research. 24: 409-12. PMID 9888515 DOI: 10.3109/07435809809032623  0.382
Show low-probability matches.